Barcoding Triple-Negative Breast Cancer Cells with Fluorescent Proteins to Examine Properties of Metastatic Cells – UROP Spring Symposium 2023

Barcoding Triple-Negative Breast Cancer Cells with Fluorescent Proteins to Examine Properties of Metastatic Cells

Yi-Hsien Eu

Yi-Hsien Eu photo

Pronouns: she/her/hers

Research Mentor(s): Mark Slayton
Research Mentor School/College/Department: Internal Medicine, Hematology & Oncology / Medicine
Program: UROP
Session: Session 6 (3:40pm – 4:30pm)
Authors: Yi-Hsien Eu, Mark Slayton, Zackariah Farah, Ehsanul Hoque-Apu, Ryan Oliver, Sofia Merajver

Abstract

Due to the lethal complications that arise from metastasis to the brain, it is of utmost importance to detect a tumor’s metastatic potential. This project aims to improve upon an existing blood brain barrier on a chip device that tests triple-negative breast cancer cells’ potential to metastasize to the brain. In order to gather data from the cells that infiltrate the microfluidic blood-brian barrier model, the cancer cells are barcoded with fluorescent labels: GFP, cerulean, cherry, and EBFP, via transduction. The cells that do metastasize are uniquely identified and can therefore be isolated to study its properties, such as migratory behavior, gene expression, and therapeutic testing.

Health Science

lsa logoum logo